Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer
A targeted ultra-deep NGS assay for detecting tumor-derived ctDNA based on fragment-level hypermethylation of CpG-rich cfDNA is developed and enables highly specific, non-invasive hypermethylated ctDNA detection in HBOC populations.